financetom
Business
financetom
/
Business
/
Brainstorm Cell Therapeutics to Delist From Nasdaq
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brainstorm Cell Therapeutics to Delist From Nasdaq
Jul 17, 2025 2:53 PM

05:30 PM EDT, 07/17/2025 (MT Newswires) -- Brainstorm Cell Therapeutics ( BCLI ) said late Thursday its shares will be delisted from Nasdaq after it failed to comply with the minimum shareholder equity requirement.

Trading of its stock will be suspended at the open of trading on July 18, the firm said. It added that it has secured approval for its stock to be quoted on the OTCQB Venture Market Friday.

Shares were down over 40% during after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Silver Spruce Provides Update on Acquisition of Remaining 50% Interest in Jackie Gold-Silver Project, Sonora, Mexico
Silver Spruce Provides Update on Acquisition of Remaining 50% Interest in Jackie Gold-Silver Project, Sonora, Mexico
Nov 12, 2025
BEDFORD, NS / ACCESS Newswire / November 12, 2025 / Silver Spruce Resources Inc. (Silver Spruce or the Company) is pleased to report that it signed an amending agreement with Colibri Resource Corporation (Colibri) (TSXV:CBI) dated November 12, 2025 in respect of the proposed acquisition by the Company of Colibri's 50% interest in the Jackie Au-Ag Project located in Sonora,...
Kodiak AI Q3 Loss Widens, Revenue Rises
Kodiak AI Q3 Loss Widens, Revenue Rises
Nov 12, 2025
05:58 PM EST, 11/12/2025 (MT Newswires) -- Kodiak AI (KDK) reported a Q3 net loss late Wednesday of $3.89 per diluted share, widening from a loss of $0.33 a year earlier. Revenue for the quarter ended Sept. 30 was $770,000, up from $400,000 a year earlier. Shares were down over 3% in after-hours trading. ...
Backwater to breakout: Investors pivot to Australian small caps as blue-chip premiums bite
Backwater to breakout: Investors pivot to Australian small caps as blue-chip premiums bite
Nov 12, 2025
By Rajasik Mukherjee (Reuters) -Long overlooked as the backwater of the Australian equity market, small-cap stocks are having their best run in over a decade due to strong earnings and growth potential, as pricey blue-chip stocks have sent investors seeking value elsewhere, fund managers say. Powered by robust earnings, easing interest rates and a policy tailwind for critical minerals, the...
Atlassian Insider Sold Shares Worth $1,228,731, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,228,731, According to a Recent SEC Filing
Nov 12, 2025
05:56 PM EST, 11/12/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, CEO, Co-Founder, on November 11, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,228,731. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 260,610 Class A common shares of the company, with 260,610 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000166612025000066/xslF345X05/primarydocument.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved